Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression

Journal of Alzheimer's Disease

Volumn 36, Issue 1, 2013, Pages 7-20

  Semar, Sandra ^a   Klotz, Markus ^a   Letiembre, Maryse ^a   Van Ginneken, Chris ^c   Braun, Anne ^a   Jost, Viktor ^a   Bischof, Michael ^a   Lammers, Wim J ^e   Liu, Yang ^b   Fassbender, Klaus ^b   Wyss Coray, Tony ^d   Kirchhoff, Frank ^b   Schafer, Karl Herbert ^a,f  

^a UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^f UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Alzheimer's disease; amyloid protein precursor; enteric nervous system; potential biomarker

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; TOLL LIKE RECEPTOR 4;

AGE; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN TISSUE; CELL DENSITY; CELL MOTILITY; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; EARLY DIAGNOSIS; GASTROINTESTINAL MOTILITY; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; INTESTINE INNERVATION; MAZE TEST; MOUSE; MYENTERIC PLEXUS; NEOCORTEX; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE; THALAMUS; WESTERN BLOTTING;

EID: 84878853075     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-120511     Document Type: Article

References (48)

1. Maddalena A, Papassotiropoulos A, Müller-Tillmanns B, Jung HH, Hegi T, Nitsch RM, Hock C (2003) Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to betaamyloid peptide42. Arch Neurol 60, 1202-1206.
2. Barber RC (2010) Biomarkers for early detection of Alzheimer disease. J Am Osteopath Assoc 110, 10-15.
3. Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss Ma, Seubert P (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 55, 937-945.
4. Yin YI, Bassit B, Zhu L, Yang X, Wang C, Li Y-M (2007) gamma-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: Implications for Alzheimer disease. J Biol Chem 282, 23639-23644.
5. Furness JB (2006) The enteric nervous system, Blackwell Publishing.
6. Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's diseaserelated brain pathology. Neurosci Lett 396, 67-72.
7. Singaram C, AshrafW, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer RQE (1995) Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. J Biol Chem 346, 861-864.
8. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57, 456-462.
9. Wang L, Fleming SM, Chesselet M-F, TachéY(2008) Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuroreport 19, 873-876.
10. Cabal A, Alonso-Cortina V, Gonzalez-Vazquez LO, Naves FJ, DelValle ME,Vega Ja (1995) beta-Amyloid precursor protein (beta APP) in human gut with special reference to the enteric nervous system. Brain Res Bull 38, 417-423.
11. Arai H, Lee VM,Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ (1991) Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol 30, 686-693.
12. Steen LE, Oberg L (1983) Familial amyloidosis with polyneuropathy: Roentgenological and gastroscopic appearance of gastrointestinal involvement. Am J Gastroenterol 78, 417-420.
13. Ginneken C, Van, Schäfer K-H, Van Dam D, Huygelen V, De Deyn PP (2011) Morphological changes in the enteric nervous system of aging and APP23 transgenic mice. Brain Res 1378, 43-53.
14. Crews L, Rockenstein E, Masliah E (2010) APP transgenic modeling of Alzheimer's disease: Mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct Funct 214, 111-126.
15. Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 66, 573-582.
16. Sturchler-Pierrat C, Abramowski D, Duke M,Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 94, 13287-13292.
17. VanVickle GD, Esh CL, KalbackWM,Patton RL, Luehrs DC, Kokjohn TA, Fifield FG, Fraser PE, Westaway D, McLaurin J, Lopez J, Brune D, Newel AJ, Poston M, Beach TG, Roher AE (2007) TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. Biochemistry 46, 10317-10327.
18. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13, 159-170.
19. Jung S, Aliberti J, Graemmel P, Sunshine MJ, KreutzbergGW, Sher A, Littman DR (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20, 4106-14.
20. Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F (2004) Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol Aging 25, 861-871.
21. Chishti MA, Yang D, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-hyslop PS, George-hyslop S (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. Biochemistry 276, 21562-21570.
22. Schäfer K-H, Saffrey MJ, Burnstock G, Mestres-Ventura P (1997) A new method for the isolation of myenteric plexus from the newborn rat gastrointestinal tract. Brain Res Brain Res Protoc 1, 109-113.
23. Seerden TC, Lammers WJEP, De Winter BY, De Man JG, Pelckmans P a (2005) Spatiotemporal electrical and motility mapping of distension-induced propagating oscillations in the murine small intestine. Am J Physiol Gastrointest Liver Physiol 289, 1043-1051.
24. Galimberti D, Scarpini E (2012) Progress in Alzheimer's disease. J Neurol 295, 201-211.
25. Stone JG, Casadesus G, Gustaw-Rothenberg K, Siedlak SL, Wang X, Zhu X, Perry G, Castellani RJ, Smith MA (2011) Frontiers in Alzheimer's disease therapeutics. Ther Adv Chronic Dis 2, 9-23.
26. Park WH, Choi SO, Kwon KY, Chang ES (1992) Acetylcholinesterase histochemistry of rectal suction biopsies in the diagnosis of Hirschsprung's disease. J Korean Med Sci 7, 353-359.
27. Hirsch B, Angelides A, Goode S, Garb J (2011) Rectal biopsies obtained with jumbo biopsy forceps in the evaluation of Hirschsprung disease. J Pediatr Gastroenterol Nutr 52, 429-432.
28. Knowles CH, Veress B, Kapur RP,Wedel T, Farrugia G, Vanderwinden J-M, Geboes K, SmithVV,Martin JE, LindbergG, Milla PJ, De Giorgio R (2011) Quantitation of cellular components of the enteric nervous system in the normal human gastrointestinal tract-report on behalf of the Gastro 2009 International Working Group. Neurogastroenterol Motil 23, 115-124.
29. Shankle WR, Landing BH, Ang SM, Chui H, Villarreal-Engelhardt G, Zarow C (1993) Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: Enteric neurons in Alzheimer disease. Mod Pathol 6, 10-14.
30. Hagl CI, Wink E, Scherf S, Heumüller-Klug S, Hausott B, Schäfer K-H (2013) FGF2 deficit during development leads to specific neuronal cell loss in the enteric nervous system. Histochem Cell Biol 139, 47-57.
31. Alonso-Cortina VL, González-Vázquez LO, Cabal A, Esteban I, Vega JA (1995) Immunoreactivity for beta/A4 protein, but not for its precursor, in human chromaffin cells. Brain Res Bull 37, 449-455.
32. Young HM, Bergner AJ,Müller T (2003) Acquisition of neuronal and glial markers by neural crest-derived cells in the mouse intestine. J Comp Neurol 456, 1-11.
33. Calissano P, Matrone C, Amadoro G (2010) Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease. Dev Neurobiol 70, 372-383.
34. Matrone C, Barbagallo a. PM, La Rosa LR, Florenzano F, Ciotti MT, Mercanti D, Chao M V., Calissano P, D'Adamio L (2011) APP is phosphorylated by TrkA and regulates NGF/TrkA signaling. J Neurosci 31, 11756-11761.
35. Anan I, El-Salhy M, Ando Y, Terazaki H, Suhr OB (2001) Comparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathy. Acta Neuropathol 102, 227-232.
36. Obayashi K, Olsson M, Anan I, Ueda M, Nakamura M, Okamoto S, Yamashita T, Miida T, Ando Y, Suhr OB (2008) Impact of serotonin transporter and catechol-O-methyl transferase genes polymorphism on gastrointestinal dysfunction in Swedish and Japanese familial amyloidotic polyneuropathy patients. Clin Chim Acta 398, 10-14.
37. Anan I, El-Salhy M, Ando Y, Forsgren S, Nyhlin N, Terazaki H, Sakashita N, Suhr OB (1999) Colonic enteric nervous system in patients with familial amyloidotic neuropathy. Acta Neuropathol 98, 48-54.
38. Sze C (2000) Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J Neurol Sci 175, 81-90.
39. Ermini FV, Grathwohl S, Radde R,Yamaguchi M, Staufenbiel M, Palmer TD, JuckerM(2008) Neurogenesis and alterations of neural stem cells in mouse models of cerebral amyloidosis. Am J Pathol 172, 1520-1528.
40. Stewart HJ, Jessen KR, Curtis R, Mirsky R (1992) Schwann cells, neurons and GAP-43. Perspect Dev Neurobiol 1, 45-52.
41. Pizza V, Agresta A, D'Acunto CW, Festa M, Capasso A (2011) Neuroinflammation and ageing: Current theories and an overview of the data. Rev Recent Clin Trials 6, 189-203.
42. Rumio C, Besusso D, Arnaboldi F, Palazzo M, Selleri S, Gariboldi S, Akira S, Uematsu S, Bignami P, Balsari A, Ceriani V, Me S (2006) Activation of smooth muscle and myenteric plexus cells of jejunum via toll-like receptor 4. J Cell Physiol 54, 47-54.
43. Song M, Jin J, Lim J-E, Kou J, Pattanayak A, Rehman Ja, Kim H-D, Tahara K, Lalonde R, Fukuchi K-I (2011) TLR4 mutation reduces microglial activation, increases Abeta deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease. J Neuroinflammation 8, 92.
44. Graeber MB, Streit WJ(2010) Microglia: Biology and pathology. Acta Neuropathol 119, 89-105.
45. Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal tract: Implications for Parkinson disease. Mov Disord 23, 1065-1075.
46. Andrada MJP, Cano FEM, Morales I, Camello C, Barriga F, Moreno MC, Hernandez DCP (2012) Changes in colonic Motility in a murine model of Alzheimers disease. Neurogastroenterol Motil 24, 50.
47. Braun A, Bischof M, Grimm M, Hartmann T, Krämer S, Schönfeld ASK (2012) The influence of amyloid. protein upon enteric neurons. Neurogastroenterol Motil 24, 122.
48. Hagl CI, Thil O, Holland-Cunz S, Faissner R,Wandschneider S, Schnölzer M, Löhr M, Schäfer K-H (2005) Proteome analysis of isolated myenteric plexus reveals significant changes in protein expression during postnatal development. Auton Neurosci 122, 1-8.